United States (US) Irritable Bowel Syndrome (IBS) Market (2025-2031) | Outlook, Forecast, Segmentation, Growth, Size & Revenue, Analysis, Industry, Companies, Competitive Landscape, Share, Trends, Value

Name: United States (US) Irritable Bowel Syndrome (IBS) Market (2025-2031) | Trends & Outlook
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Drug Type (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Others), By Medical Condition (IBS-Constipation, IBS-diarrhea, Mixed), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By End-Users (Hospitals, Clinics, Homecare Settings) And Competitive Landscape

Product Code: ETC9968610	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Irritable Bowel Syndrome (IBS) Market Outlook
Market Size of United States (US) Irritable Bowel Syndrome (IBS) Market, 2024
Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market, 2031
Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Revenues & Volume for the Period 2021- 2031
United States (US) Irritable Bowel Syndrome (IBS) Market Trend Evolution
United States (US) Irritable Bowel Syndrome (IBS) Market Drivers and Challenges
United States (US) Irritable Bowel Syndrome (IBS) Price Trends
United States (US) Irritable Bowel Syndrome (IBS) Porter's Five Forces
United States (US) Irritable Bowel Syndrome (IBS) Industry Life Cycle
Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Drug Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Lubiprostone for the Period 2021- 2031
Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Linaclotide for the Period 2021- 2031
Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Eluxadoline for the Period 2021- 2031
Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Rifaximin for the Period 2021- 2031
Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Alosetron for the Period 2021- 2031
Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Medical Condition for the Period 2021- 2031
Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By IBS-Constipation for the Period 2021- 2031
Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By IBS-diarrhea for the Period 2021- 2031
Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Mixed for the Period 2021- 2031
Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Hospital Pharmacies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Online Pharmacies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Retail Pharmacies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By End-Users for the Period 2021- 2031
Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Hospitals for the Period 2021- 2031
Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Clinics for the Period 2021- 2031
Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Homecare Settings for the Period 2021- 2031
United States (US) Irritable Bowel Syndrome (IBS) Import Export Trade Statistics
Market Opportunity Assessment By Drug Type
Market Opportunity Assessment By Medical Condition
Market Opportunity Assessment By Distribution Channel
Market Opportunity Assessment By End-Users
United States (US) Irritable Bowel Syndrome (IBS) Top Companies Market Share
United States (US) Irritable Bowel Syndrome (IBS) Competitive Benchmarking By Technical and Operational Parameters
United States (US) Irritable Bowel Syndrome (IBS) Company Profiles
United States (US) Irritable Bowel Syndrome (IBS) Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Irritable Bowel Syndrome (IBS) Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Irritable Bowel Syndrome (IBS) Market - Industry Life Cycle

3.4 United States (US) Irritable Bowel Syndrome (IBS) Market - Porter's Five Forces

3.5 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.6 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Medical Condition, 2021 & 2031F

3.7 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

3.8 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By End-Users, 2021 & 2031F

4 United States (US) Irritable Bowel Syndrome (IBS) Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness and diagnosis rates of irritable bowel syndrome (IBS) in the United States.

4.2.2 Growing demand for effective IBS treatments and therapies.

4.2.3 Technological advancements in diagnostic tools and treatment options for IBS patients.

4.3 Market Restraints

4.3.1 Lack of definitive diagnostic tests for IBS, leading to misdiagnosis and delayed treatment.

4.3.2 High cost associated with specialized IBS treatments and therapies.

4.3.3 Regulatory challenges and stringent approval processes for new IBS medications.

5 United States (US) Irritable Bowel Syndrome (IBS) Market Trends

6 United States (US) Irritable Bowel Syndrome (IBS) Market, By Types

6.1 United States (US) Irritable Bowel Syndrome (IBS) Market, By Drug Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Drug Type, 2021- 2031F

6.1.3 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Lubiprostone, 2021- 2031F

6.1.4 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Linaclotide, 2021- 2031F

6.1.5 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Eluxadoline, 2021- 2031F

6.1.6 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Rifaximin, 2021- 2031F

6.1.7 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Alosetron, 2021- 2031F

6.1.8 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Irritable Bowel Syndrome (IBS) Market, By Medical Condition

6.2.1 Overview and Analysis

6.2.2 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By IBS-Constipation, 2021- 2031F

6.2.3 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By IBS-diarrhea, 2021- 2031F

6.2.4 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Mixed, 2021- 2031F

6.3 United States (US) Irritable Bowel Syndrome (IBS) Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.3.3 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

6.3.4 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.4 United States (US) Irritable Bowel Syndrome (IBS) Market, By End-Users

6.4.1 Overview and Analysis

6.4.2 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Homecare Settings, 2021- 2031F

7 United States (US) Irritable Bowel Syndrome (IBS) Market Import-Export Trade Statistics

7.1 United States (US) Irritable Bowel Syndrome (IBS) Market Export to Major Countries

7.2 United States (US) Irritable Bowel Syndrome (IBS) Market Imports from Major Countries

8 United States (US) Irritable Bowel Syndrome (IBS) Market Key Performance Indicators

8.1 Patient-reported outcomes (PROs) related to symptom improvement and quality of life after treatment.

8.2 Adoption rates of emerging digital health solutions for IBS management.

8.3 Number of clinical trials and research studies focused on developing novel IBS treatments.

8.4 Healthcare provider adherence to clinical guidelines for IBS diagnosis and treatment.

8.5 Patient adherence and compliance rates with prescribed IBS treatments and therapies.

9 United States (US) Irritable Bowel Syndrome (IBS) Market - Opportunity Assessment

9.1 United States (US) Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.2 United States (US) Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Medical Condition, 2021 & 2031F

9.3 United States (US) Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

9.4 United States (US) Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By End-Users, 2021 & 2031F

10 United States (US) Irritable Bowel Syndrome (IBS) Market - Competitive Landscape

10.1 United States (US) Irritable Bowel Syndrome (IBS) Market Revenue Share, By Companies, 2024

10.2 United States (US) Irritable Bowel Syndrome (IBS) Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Estonia Irritable Bowel Syndrome (IBS) Market

Ethiopia Irritable Bowel Syndrome (IBS) Market

Fiji Irritable Bowel Syndrome (IBS) Market

Finland Irritable Bowel Syndrome (IBS) Market

Gabon Irritable Bowel Syndrome (IBS) Market

Global Irritable Bowel Syndrome (IBS) Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here